| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Young-Joo Kim, Kyoung-Min Par. Possible Mechanisms for Adverse Cardiac Events Caused by Exercise-Induced Hypertension in Long-Distance Middle-Aged Runners: A Review. Journal of clinical medicine. vol 13. issue 8. 2024-04-27. PMID:38673457. |
however, hypertrophic cardiomyopathy is the leading cause of scd among those <35 years of age. |
2024-04-27 |
2024-04-29 |
Not clear |
| Xinyu Zhu, Yuan Tian, Ying Shi, Jianxiu Lian, Honghu Shen, Lulu Li, Haishan Wu, Pengfei Li. The feasibility of left ventricular strain and strain rate for evaluating patients with risk factors of sudden cardiac death in hypertrophic cardiomyopathy by Feature-tracking Cardiac Magnetic Resonance. The American journal of cardiology. 2024-04-20. PMID:38642869. |
sudden cardiac death (scd) represents the most severe complication of hypertrophic cardiomyopathy (hcm). |
2024-04-20 |
2024-04-23 |
Not clear |
| Plamen Bokov, Bérengère Koehl, Benjamin Dudoignon, Malika Benkerrou, Christophe Delclau. Case-control study of heart rate variability and sleep apnea in childhood sickle cell disease. Journal of sleep research. 2024-04-09. PMID:38590226. |
children with scd had lower bmi z-scores and more tonsil hypertrophy than control children. |
2024-04-09 |
2024-04-11 |
Not clear |
| Max Liebregt. Trans-Atlantic Differences in Approach to Sudden Death Prevention in Hypertrophic Cardiomyopathy. The Canadian journal of cardiology. 2024-03-24. PMID:38522619. |
the american approach to predicting sudden cardiac death (scd) in patients with hypertrophic cardiomyopathy (hcm) diverges from the european method in that it relies on major risk factors independently justifying the implantation of an (implantable cardioverter-defibrillator) icd for primary prevention, whereas the european approach utilizes a mathematical equation to estimate a 5-year risk percentage. |
2024-03-24 |
2024-03-27 |
Not clear |
| Marta Ribeiro, Joanna Jager, Marta Furtado, Teresa Carvalho, Joaquim M S Cabral, Dulce Brito, Maria Carmo-Fonseca, Sandra Martins, Simão Teixeira da Roch. Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutations. Stem cell research. vol 76. 2024-02-28. PMID:38417376. |
familial hypertrophic cardiomyopathy (hcm) stands as a predominant heart condition, characterised by left ventricle hypertrophy in the absence of any associated loading conditions, with affected individuals having an increased risk of developing heart failure and sudden cardiac death (scd). |
2024-02-28 |
2024-03-02 |
Not clear |
| Keitaro Akita, Kohei Hasegawa, Michael A Fifer, Albree Tower-Rader, Jeeyoun Jung, Mathew S Maurer, Muredach P Reilly, Yuichi J Shimad. Prediction of cardiac death in patients with hypertrophic cardiomyopathy using plasma adipokine levels. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2024-02-25. PMID:38403486. |
hypertrophic cardiomyopathy (hcm) causes cardiac death through both sudden cardiac death (scd) and death due to heart failure (hf). |
2024-02-25 |
2024-02-28 |
Not clear |
| James McKinney, Megan Isserow, Justin Wong, Saul Isserow, Nathaniel Moulso. New insights and recommendations for athletes with Hypertrophic Cardiomyopathy. The Canadian journal of cardiology. 2024-02-18. PMID:38369259. |
hypertrophic cardiomyopathy (hcm) has long been considered a high-risk cardiac condition for which exercise was felt to increase the risk of sudden cardiac death (scd). |
2024-02-18 |
2024-02-21 |
Not clear |
| Martin S Maron, Ethan J Rowin, Barry J Maro. The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy. The American journal of cardiology. vol 212S. 2024-02-17. PMID:38368038. |
hypertrophic cardiomyopathy (hcm) is a relatively common and, often, inherited cardiac disease, once regarded as largely untreatable with ominous prognosis and, perhaps, most visibly as a common cause of sudden cardiac death (scd) in the young. |
2024-02-17 |
2024-02-20 |
Not clear |
| Madeleine Townsend, Aamir Jeewa, Michael Khoury, Chentel Cunningham, Kristen George, Jennifer Conwa. Unique Aspects of Hypertrophic Cardiomyopathy in Children. The Canadian journal of cardiology. 2024-01-20. PMID:38244986. |
hypertrophic cardiomyopathy (hcm) is a primary heart muscle disease characterized by left ventricular hypertrophy that can be asymptomatic or with presentations that vary from left ventricular outflow tract obstruction, heart failure from diastolic dysfunction, arrhythmias, and/or sudden cardiac death (scd). |
2024-01-20 |
2024-01-23 |
Not clear |
| Hyun-Jung Lee, Hyung-Kwan Kim, Sang Chol Lee, Jihoon Kim, Jun-Bean Park, Seung-Pyo Lee, Yong-Jin Ki. Performance of 2020 AHA/ACC HCM Guidelines and Incremental Value of Myocardial Strain for Predicting SCD. JACC. Asia. vol 4. issue 1. 2024-01-15. PMID:38222259. |
the 2020 american heart association (aha)/american college of cardiology (acc) guidelines for sudden cardiac death (scd) risk stratification in hypertrophic cardiomyopathy (hcm) need further international validation. |
2024-01-15 |
2024-01-17 |
Not clear |
| Olga Boleti, Gabrielle Norrish, Ella Field, Kathleen Dady, Kim Summers, Gauri Nepali, Vinay Bhole, Orhan Uzun, Amos Wong, Piers E F Daubeney, Graham Stuart, Precylia Fernandes, Karen McLeod, Maria Ilina, Muhammad Najih Liaqath Ali, Tara Bharucha, Grazia Delle Donne, Elspeth Brown, Katie Linter, Caroline B Jones, Jonathan Searle, William Regan, Sujeev Mathur, Nicola Boyd, Zdenka Reinhardt, Sophie Duignan, Terence Prendiville, Satish Adwani, Juan Pablo Kask. Natural history and outcomes in paediatric RASopathy-associated hypertrophic cardiomyopathy. ESC heart failure. 2024-01-13. PMID:38217456. |
this study aimed to describe the natural history and predictors of all-cause mortality and sudden cardiac death (scd)/equivalent events in children with a rasopathy syndrome and hypertrophic cardiomyopathy (hcm). |
2024-01-13 |
2024-01-16 |
Not clear |
| Mohammad Taghi Hedayati Goudarzi, Maryam Moradi, Saeed Abrotan, Mehrdad Saravi, Hoda Shirafkan, Rana Irilouzadian, Hossein Salehi Omra. Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy. Cardiology research and practice. vol 2023. 2024-01-11. PMID:38204930. |
hypertrophic cardiomyopathy (hcm) has different complications such as cardiac arrhythmia and sudden cardiac death (scd). |
2024-01-11 |
2024-01-13 |
Not clear |
| Zhi Du, Kai Wang, Yawei Cui, Xudong Xie, Ruoyu Zhu, Fanghong Dong, Xiaogang Gu. The China Hypertrophic Cardiomyopathy Project (CHCMP): The Rationale and Design of a Multicenter, Prospective, Registry Cohort Study. Journal of cardiovascular translational research. 2024-01-05. PMID:38180696. |
sudden cardiac death (scd) is a common cause of death in hcm patients, and identification of patients at a high risk of scd is crucial in clinical practice. the china hypertrophic cardiomyopathy project is a hospital-based, multicenter, prospective, registry cohort study of hcm patients, covering a total of 3000 participants and with a 5-year follow-up plan. |
2024-01-05 |
2024-01-07 |
human |
| Christina Menexi, Mohamed ElRefai, David Farwell, Neil Srinivasa. A cluster of inappropriate shocks in a pediatric S-ICD patient - how to troubleshoot? Indian pacing and electrophysiology journal. 2023-12-30. PMID:38159808. |
we present the case of a 16-year-old male pediatric patient diagnosed with hypertrophic cardiomyopathy (hcm, identified as having a high risk of sudden cardiac death (scd), who underwent a successful subcutaneous implantable cardiac defibrillator (s-icd) implantation as a primary prevention measure in 2018. |
2023-12-30 |
2024-01-05 |
Not clear |
| Sophia Schulze Lammers, Thorsten Lawrenz, Dennis Lawin, Annika Hoyer, Christoph Stellbrink, Urs-Vito Albrech. Prolonged mHealth-Based Arrhythmia Monitoring in Patients With Hypertrophic Cardiomyopathy (HCM-PATCH): Protocol for a Single-Center Cohort Study. JMIR research protocols. vol 12. 2023-12-29. PMID:38157231. |
patients with hypertrophic cardiomyopathy (hcm) are at increased risk of sudden cardiac death (scd) due to ventricular arrhythmias and other arrhythmias. |
2023-12-29 |
2024-01-05 |
Not clear |
| Verena Wilmes, Luise Mildeberger, Marcel A Verhoff, Silke Kauferstei. Influence of microRNAs on iNOS expression in postmortem human infarction hearts. Forensic science international. vol 354. 2023-12-27. PMID:38150896. |
a growing list of mirnas are dysregulated in cardiac arrhythmias, contractility diseases, myocardial infarction (mi), sudden cardiac death (scd), chronic heart failure and hypertrophy. |
2023-12-27 |
2023-12-30 |
human |
| Yuki Ito, Heima Sakaguchi, Etsuko Tsuda, Kenichi Kurosak. Effect of beta-blockers and exercise restriction on the prevention of sudden cardiac death in pediatric hypertrophic cardiomyopathy. Journal of cardiology. 2023-12-03. PMID:38043708. |
risk assessment tools and effective prevention strategies for sudden cardiac death (scd) in pediatric patients with hypertrophic cardiomyopathy (hcm) have not been established. |
2023-12-03 |
2023-12-10 |
Not clear |
| Rui Zhang, Fan Zhao, Jing Wang, Yahong Qin, Tingting Wang, Ai-Ai Ch. Case Report: Integrated echocardiographic assessment guided Liwen procedure for treating obstructive hypertrophic cardiomyopathy with ventricular aneurysm. Frontiers in cardiovascular medicine. vol 10. 2023-12-01. PMID:38028451. |
hypertrophic cardiomyopathy (hcm) is a genetic myocardial disease, with an estimated incidence of 0.2%-6%, and is the main cause of sudden cardiac death (scd) in young athletes. |
2023-12-01 |
2023-12-10 |
Not clear |
| Levent Pay, Tuğba Çetin, Şeyda Dereli, Hikmet Kadı, Ahmet Çağdaş Yumurtaş, Tufan Çınar, Mert İlker Hayıroğl. Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy and future perspectives. Pacing and clinical electrophysiology : PACE. 2023-11-21. PMID:37987551. |
the hypertrophic cardiomyopathy (hcm) risk- sudden cardiac death (scd) model provides a convenient tool for determining the risk of scd in patients with hcm even though some patients with low-risk scores still remain at risk of scd. |
2023-11-21 |
2023-11-29 |
Not clear |
| b' Marija Polovina, Carsten Tsch\\xc3\\xb6pe, Giuseppe Rosano, Marco Metra, Filippo Crea, Wilfried Mullens, Johann Bauersachs, Karen Sliwa, Rudolf A de Boer, Dimitrios Farmakis, Thomas Thum, Domenico Corrado, Antoni Bayes Genis, Biykem Bozkurt, Gerasimos Filippatos, Andre Keren, Hadi Skouri, Brenda Moura, Maurizio Volterrani, Magdy Abdelhamid, Milika A\\xc5\\xa1anin, Gordana Krljanac, Milenko Tomi\\xc4\\x87, Gianluigi Savarese, Marianna Adamo, Yuri Lopatin, Ovidiu Chioncel, Andrew Js Coats, Petar M Seferovi\\xc4\\x8. Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies. European journal of heart failure. 2023-10-31. PMID:37905371.' |
in this review, we aim to provide an in-depth discussion of the contemporary concepts pertinent to understanding the burden, risk assessment and prevention of scd in cardiomyopathies (dilated, non-dilated left ventricular, hypertrophic, arrhythmogenic right ventricular, and restrictive). |
2023-10-31 |
2023-11-08 |
Not clear |